Wednesday, December 2, 2020 at 11:00 AM—12:30 PM Eastern
Kirk L. Cumpston, DO
President of the American Academy of Clinical Toxicology
Elise Madison Lewis, PhD
President of the Society for Birth Defects Research and Prevention
Lawrence D. Sloan, CAE
CEO of the American Industrial Hygiene Association
The roundtable will be facilitated by Anne H. Chappelle, PhD, DABT, Chair of the Scientific Liaison Coalition (SLC).
Abstract: The global COVID-19 pandemic caused significant disruptions, delays, and cancellations of scientific meetings in 2020. You are invited to attend a facilitated roundtable where leaders of three organizations will share their recent experiences in transitioning from the traditional ‘in person’ scientific meeting to a virtual experience. The goal is to engage in a discussion about:
- Criteria that were used for virtual platform selection and agenda planning
- How essential meeting components (e.g. networking, poster sessions, vendor exhibits) were addressed
- Key learnings when planning and executing this format
- Current thinking regarding the ongoing impact of the pandemic on scientific meetings in 2021
The target audience for this roundtable includes leaders and volunteers involved in the planning of their scientific organizations’ meetings as well as staff or contractors who support the planning and execution of such meetings. Click here for more information.
Registration is offered to AACT members, and there is no cost to participate.